3EOA PDB NFT

Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba

IPFS of NFT metadata:

bafybeibyvfto2e5p6jm6kvyvz6okifb7xqnacxyvdmn2crqivzcjgqxjma/metadata.json

IPFS of structure file:

bafybeigxvxr3pnwgu4wloecbla7jni5rbmjz3uiorp2tlgydcyoyiswcwy/3eoa.pdb

MOLNFT PDB v1

NFT id:
62731
PDB ID:
3EOA
Name:
Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I
Keywords:
IMMUNE SYSTEM/CELL ADHESION
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.80

NFT data

MolNFT PDB v1 is The Protein Data Bank database (URL: https://rcsb.org) of protein structures minted as ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, P.E. Bourne.
(2000) The Protein Data Bank Nucleic Acids Research, 28: 235-242.

MOLNFT 3EOA research and analysis (ICN3D with VR)

FASTA sequences

>3eoa_L mol:protein length:214 Efalizumab Fab fragment, light chain
DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
>3eoa_A mol:protein length:214 Efalizumab Fab fragment, light chain
DIQMTQSPSSLSASVGDRVTITCRASKTISKYLAWYQQKPGKAPKLLIYSGSTLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQHNEYPLTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC
>3eoa_H mol:protein length:220 Efalizumab Fab fragment, heavy chain
EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVE
>3eoa_B mol:protein length:220 Efalizumab Fab fragment, heavy chain
EVQLVESGGGLVQPGGSLRLSCAASGYSFTGHWMNWVRQAPGKGLEWVGMIHPSDSETRYNQKFKDRFTISVDKSKNTLYLQMNSLRAEDTAVYYCARGIYFYGTTYFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVE
>3eoa_I mol:protein length:181 Integrin alpha-L
GNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKRKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYV
>3eoa_J mol:protein length:181 Integrin alpha-L
GNVDLVFLFDGSMSLQPDEFQKILDFMKDVMKKLSNTSYQFAAVQFSTSYKTEFDFSDYVKRKDPDALLKHVKHMLLLTNTFGAINYVATEVFREELGARPDATKVLIIITDGEATDSGNIDAAKDIIRYIIGIGKHFQTKESQETLHKFASKPASEFVKILDTFEKLKDLFTELQKKIYV

References and links

Current molecular structure file and data about current molecular structure file and NFT token based on it with
PDBID: 3EOA
TITLE: Crystal structure the Fab fragment of Efalizumab in complex with LFA-1 I domain, Form I
DOI: 10.1073/pnas.0810844106
AUTHORS: Li, S., Ding, J.
ACCESSION DATE: 09/26/08
Obtained at RCSB PDB https://rcsb.org
RCSB Link: https://www.rcsb.org/structure/3EOA